Everest Re Group, Ltd. (EG)

FairStock Score: 71/100 — STEADY

Key Financials

Strengths

• Trading at significant discount to book value (0.83 P/B) with Graham Number protection at $303.39
• Strong underwriting margin of 10.32% in latest quarter demonstrates operational competence
• Conservative leverage with D/E of 0.24 provides financial flexibility and stability
• Low beta of 0.33 indicates defensive characteristics suitable for risk-averse investors
• Established market position in reinsurance with diversified geographic exposure

Concerns

• Alarming negative free cash flow of -$22.3B signals potential balance sheet deterioration or catastrophic capital deployment
• Altman Z-Score of 0.61 places company in financial distress territory with elevated bankruptcy risk
• Abysmal ROCE of 2.22% indicates capital is being destroyed rather than compounded at acceptable returns
• Piotroski F-Score of 5/9 reveals deteriorating financial position across multiple dimensions

AI Analysis

Everest Re presents an intriguing but problematic case study in reinsurance value. On the surface, we see a company trading at 8.36x earnings with a price-to-book of 0.83—well below Graham's margin of safety at $303.39. The Graham Number suggests modest downside protection. However, I must temper my enthusiasm considerably. The Altman Z-Score of 0.61 signals financial distress, placing the company in the danger zone. More troubling is the negative $22.3B free cash flow and -3.0% FCF yield, which defy explanation and demand scrutiny. The Piotroski F-Score of 5/9 confirms deteriorating financial health. While the latest quarter shows respectable $4.3B revenue with a 10.32% margin and $446M net income, these snapshots cannot overcome systemic concerns. The 10.85% ROE is mediocre for insurance, and a 2.22% ROCE is frankly dismal—we're not creating shareholder value at acceptable rates. The low debt-to-equity of 0.24 provides flexibility, and the modest beta of 0.33 shows stability. Yet without positive free cash flow and improving returns on capital, I cannot justify investment here. The FairStock Score of 63/100 reflects this ambivalence. This appears to be a value trap—the low multiples exist for legitimate reasons. Until we see sustained positive FCF, improving ROCE toward 10%+, and a more convincing F-Score, I remain a reluctant observer rather than buyer.

Bull Case

If the negative FCF represents a temporary capital allocation anomaly (catastrophe reserves, acquisitions, or accounting adjustments), Everest's 10.85% ROE and strong underwriting margins could justify the valuation. A rebound to normalized free cash flow generation combined with improving ROCE would make this a compelling deep-value opportunity at current levels, with 25-35% upside potential.

Bear Case

The persistent negative free cash flow, distressed Z-Score, and poor ROCE suggest Everest faces structural headwinds in the reinsurance market or management capital allocation issues. If this represents a deteriorating competitive position or mounting underwriting losses masked by accounting, the stock could compress further toward tangible book value, resulting in 20-30% downside.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer